What are the most significant risks to consider when making decisions on TB treatment regimens?

OutcomesRelative importance
Acquired drug resistance8
Failure8
Relapse8
Infecting health care workers and the community7
Default7
Loss of efficacy of HIV medicines due to poorly managed drug interactions7
Drug toxicity7
Interaction with non-TB medications6
Financial burden5

From: A3, TB treatment outcomes

Cover of Treatment of Tuberculosis: Guidelines
Treatment of Tuberculosis: Guidelines. 4th edition.
Copyright © 2010, World Health Organization.

All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 4857; e-mail: tni.ohw@sredrokoob). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: tni.ohw@snoissimrep).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.